Tags

Type your tag names separated by a space and hit enter

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
MMWR Morb Mortal Wkly Rep 2015; 64(23):647-50MM

Abstract

On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) voted that a single primary dose of yellow fever vaccine provides long-lasting protection and is adequate for most travelers. ACIP also approved recommendations for at-risk laboratory personnel and certain travelers to receive additional doses of yellow fever vaccine (Box). The ACIP Japanese Encephalitis and Yellow Fever Vaccines Workgroup evaluated published and unpublished data on yellow fever vaccine immunogenicity and safety. The evidence for benefits and risks associated with yellow fever vaccine booster doses was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. This report summarizes the evidence considered by ACIP and provides the updated recommendations for yellow fever vaccine booster doses.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26086636

Citation

Staples, J Erin, et al. "Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee On Immunization Practices, 2015." MMWR. Morbidity and Mortality Weekly Report, vol. 64, no. 23, 2015, pp. 647-50.
Staples JE, Bocchini JA, Rubin L, et al. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(23):647-50.
Staples, J. E., Bocchini, J. A., Rubin, L., & Fischer, M. (2015). Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR. Morbidity and Mortality Weekly Report, 64(23), pp. 647-50.
Staples JE, et al. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee On Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):647-50. PubMed PMID: 26086636.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. AU - Staples,J Erin, AU - Bocchini,Joseph A,Jr AU - Rubin,Lorry, AU - Fischer,Marc, AU - ,, PY - 2015/6/19/entrez PY - 2015/6/19/pubmed PY - 2015/8/26/medline SP - 647 EP - 50 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 64 IS - 23 N2 - On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) voted that a single primary dose of yellow fever vaccine provides long-lasting protection and is adequate for most travelers. ACIP also approved recommendations for at-risk laboratory personnel and certain travelers to receive additional doses of yellow fever vaccine (Box). The ACIP Japanese Encephalitis and Yellow Fever Vaccines Workgroup evaluated published and unpublished data on yellow fever vaccine immunogenicity and safety. The evidence for benefits and risks associated with yellow fever vaccine booster doses was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. This report summarizes the evidence considered by ACIP and provides the updated recommendations for yellow fever vaccine booster doses. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/26086636/full_citation L2 - https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a5.htm DB - PRIME DP - Unbound Medicine ER -